Article

8 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Service d'aide à la décision clinique
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    10 8 0 0


Annales de Dermatologie et de Vénéréologie
Vol 129, N° 4-C2  - avril 2002
pp. 523-532
Doi : DERM-04-2002-129-4-C2-0151-9638-101019-ART6
Herpès cutanéo-muqueux chez l'immunocompétent et grossesse
 

M. LECAT
[1]  Service de Gynécologie, Hôpital Robert-Debré, 48, boulevard Sérurier, 75935 Paris Cedex 19.

@@#100979@@

Les lignes suivantes correspondent à la revue de la bibliographie et tentent de répondre aux différentes questions et sous-questions de la conférence de consensus française sur la prise en charge de l'herpès cutanéo-muqueux chez l'immunocompétent, manifestations oculaires exclues

Abstract
Cutaneomucosal herpes in immunocompetent pregnant women

Genital herpes is a common sexually transmitted disease. In pregnant women, the risk of fetal contamination is high, particularly during the per and peripartum period. Certain prevention strategies have been changed with the advent of new antiviral agents and treatment protocols at the end of pregnancy remain to be evaluated. Based on a review of the literature, we discuss a few of these different questions raised at the French consensus conference on the management of cutaneomucosal herpes in immunocompentent pregnant women (ocular manifestations excluded).

  • What are the clinical features and what is the clinical course of herpes of the external genital organs in pregnant women?
  • What is the natural history of HSV infection in the pregnant woman and in serodiscordant couples?
  • What are the optimal modalities for local and general treatment, using drugs or not, for pregnant women (including prevention of mother-infant transmission)?
  • What are the perspectives for diagnosis, treatment and prevention of HSV1 and HSV2 infection in the pregnant woman?






© 2002 Elsevier Masson SAS. Tous droits réservés.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline